Dana-Farber Cancer Institute
Boston, MA
Post-doctoral position available in the laboratory of Dr. Geoffrey Shapiro at the Dana-Farber Cancer Institute and Harvard Medical School. The fellow will engage in studies of cyclin-dependent kinase (CDK) inhibitors in models of ER+ breast cancer and other CDK4-dependent cancers, with an overarching theme of reversing CDK inhibitor resistance. Located in Boston and the surrounding communities, Dana-Farber Cancer Institute is a leader in life changing breakthroughs in cancer research and patient care. We are united in our mission of conquering cancer, HIV/AIDS, and related diseases. We strive to create an inclusive, diverse, and equitable environment where we provide compassionate and comprehensive care to patients of all backgrounds, and design programs to promote public health particularly among high-risk and underserved populations. We conduct groundbreaking research that advances treatment, we educate tomorrow's physician/researchers,...
|
Research
|